Quantum-Si incorporated (QSI)

Market Cap	175.83M -23.8%
Revenue (ttm)	1.61M -53.0%
Net Income	-98.52M
EPS	-0.46
Shares Out	218.88M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,875,579
Open	0.8500
Previous Close	0.8473
Day's Range	0.7955 - 0.8550
52-Week Range	0.6900 - 3.1000
Beta	3.25
Analysts	Buy
Price Target	2.30 (+186.32%)
Earnings Date	Aug 13, 2026

About QSI

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer’s protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 145
• Stock Exchange: NASDAQ
• Ticker Symbol: QSI
• Website: https://www.quantum-si.com

Financial Performance

In 2025, Quantum-Si incorporated's revenue was $2.44 million, a decrease of -20.34% compared to the previous year's $3.06 million. Losses were -$101.34 million, 0.33% more than in 2024.

Analyst Summary

According to 3 analysts, the average rating for QSI stock is "Buy." The 12-month stock price target is $2.3, which is an increase of 186.32% from the latest price.

Price Target

$2.3

(186.32% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Aug 26, 2026

Data Sources Report a data error